ASA in the News
Map: How do state medical marijuana laws compare? Advocates give report card - Americans for Safe Access
By Alicia Wallace and Polly Washburn for The Cannabist
The majority of U.S. states now have a medical marijuana law in place, but the laws don’t yet go far enough, a national medical marijuana patient advocacy group says.
Americans for Safe Access recently released the latest iteration of its “Medical Marijuana Access in the United States” annual report card, in which the organization conducts a state-by-state analysis of medical marijuana laws and programs.
By Todd R. Hansen for the Daily Republic
FAIRFIELD — California, one of the original eight states to legalize medical cannabis use, received a “B+” in the 2017 annual report by Americans for Safe Access.
Overall, the organization said there is still a lot of work to do, as none of the 44 states that allow medical marijuana use received an “A” grade. However, the number of states receiving a “B” or higher went from 11 to 19.
“Medical cannabis laws are moving in a positive direction, but only a handful of the 44 medical cannabis states are truly meeting the needs of patients, and there are still six states where cannabis remains completely illegal for patients,” Steph Sherer, executive director of Americans for Safe Access, said in a statement released with the annual report.
By Carl Wellstone for Weed News
Americans for Safe Access (ASA) have been at the forefront of the movement to implement sensible cannabis laws that benefit patients battling severe and debilitating medical conditions since the organization was founded in 2002. Led by a great advocate, Steph Sherer, ASA now has over 30,000 members in with chapters in forty different states. The Washington DC-based organization has been instrumental in progress we have seen at the federal level, such as the introduction of the bipartisan CARERS Act last session. With as much knowledge on medical cannabis policy as any group, ASA has just released its report of state medical marijuana laws and it is an interesting read that illustrates the patchwork of laws across the nation and provides a grade based upon a variety of factors.
By Larry Gabriel for the Detroit Metro Times
Recently, in this era of so-called fake news and alternative facts, the organization Americans for Safe Access (ASA) struck a blow for truth in the Drug Enforcement Administration's information about marijuana.
By NBCnews for WMGT 41
Mike Liszewski, director of government affairs for the medical marijuana advocacy group Americans for Safe Access, said the reassurances “provided little comfort.” “Sessions has yet to make such a commitment to respect state medical cannabis laws,”
Liszewski said in a statement.
By George Lettis for WBAL-TV 11 Baltimore
From the complicated science of cannabis to the practical issues of a business, Americans for Safe Access also trains people to deal with the legal limbo of medical marijuana.
By Debra Borchardt for Forbes
We prepared this document to help inform Congress about four important changes in the DEA’s positions on medical cannabis that could have an impact on their policy making decisions this session: cannabis is not a 'gateway drug' and it does not cause cognitive decline, psychosis or lung cancer. - Beth Collins
By Vince Sliwoski for the Portland Mercury
Was the DEA forced to remove “alternative facts” about cannabis from its website?
YES! IN DECEMBER, the medical marijuana advocacy group, Americans for Safe Access (ASA), formally requested that the federal Drug Enforcement Agency (DEA) remove or correct a cluster of misinformation on medical cannabis from its website. Shortly thereafter, DEA complied.
By Christine Vestal for the Huffington Post
Enacted in 2014, New York’s medical marijuana law is considered among the most cautious in the nation. Americans for Safe Access, a patient advocacy group, gives the state a letter grade of C when it comes to balancing product safety and ease of access to the emerging medicine.
By Aaron G. Biros for the Cannabis Industry Journal
Members of Congress last week announced the formation of a ‘Congressional Cannabis Caucus’ in order to organize and affect cannabis policy at the federal level. Representatives Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO) and Don Young (R-AK) announced the creation of the caucus on February 16th. Cannabis advocacy and drug policy groups were quick to commend the formation of the organization.
In a joint statement issued on Friday, the National Cannabis Industry Association, the Marijuana Policy Project, the Drug Policy Alliance, NORML, Americans for Safe Access, Students for Sensible Drug Policy, Law Enforcement Action Partnership, Doctors for Cannabis Regulation, and Clergy for a New Drug Policy expressed commendation and excitement for the new group. “We commend Representatives Blumenauer, Rohrabacher, Polis, and Young for their leadership on the issue of cannabis policy,” reads the statement. “The establishment of a Cannabis Caucus will allow members from both parties, who represent diverse constituencies from around the country, to join together for the purpose of advancing sensible cannabis policy reform. It will also facilitate efforts to ease the tension between federal prohibition laws and state laws that regulate cannabis for medical and adult use.”